About Alzheimer's, Causes, Treatments And Exercises
Alzheimer's, causes, treatments and exercises
Medications Razadyne (Galantamine), Exelon (Rivastigmine) and Aricept (Donepezil)
THIS APPLICATION IS IN 2 LANGUAGES, ENGLISH AND SPANISH
Alzheimer's disease (AD), also called Alzheimer's type dementia (DSTA) or simply Alzheimer's disease, is a neurodegenerative disease manifested as cognitive impairment and behavioral disorders. It is usually characterized by an immediate loss of memory and other mental abilities (such as increased cognitive abilities) as the nerve cells (neurons) die and various areas of the brain become atrophied.
Alzheimer's causes, treatments and exercises. The disease usually has an approximate average duration after diagnosis of 10 years, although this may vary in direct proportion to the severity of the disease at the time of diagnosis.
Alzheimer's causes, treatments and exercises. Several prescription drugs are currently approved by the United States Food and Drug Administration (FDA) to treat people who have been diagnosed with Alzheimer's disease.
These medications may help delay symptoms or prevent them from getting worse for a limited time and may help control some behavioral symptoms. The drugs are: Razadyne (Galantamine), Exelon (Rivastigmine) and Aricept (Donepezil) Alzheimer's, causes, treatments and exercises.
A drug known as Namenda® (memantine), an N-methyl-D-aspartate (NMDA) antagonist, is prescribed for the treatment of moderate to severe symptoms of Alzheimer's disease. Alzheimer's causes, treatments and exercises. The main effect of these drugs is to slow the progression of some of the symptoms of moderate to severe degree of the disease.
Doctors usually begin by giving patients a low dose of the drug and gradually increase, depending on how a patient tolerates the medication. Alzheimer's causes, treatments and exercises. There is some evidence that certain patients may benefit from higher doses of cholinesterase inhibitors.
Never Miss An Update!
Follow Android Blip on Facebook / Google+